Mobile

A clinical trial to test if the drug ertugliflozin is safe and effective when compared to glimepiride in patients with Type 2 Diabetes whose sugar levels are not well controlled by treatment with meta...

Update Il y a 4 ans
Reference: EUCTR2013-003582-34

A clinical trial to test if the drug ertugliflozin is safe and effective when compared to glimepiride in patients with Type 2 Diabetes whose sugar levels are not well controlled by treatment with metaformin

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

In subjects with T2DM and inadequate glycemic control on metformin: 1. After 52 weeks, to assess the A1C-lowering efficacy of the addition of ertugliflozin 15 mg q.d. compared with the addition of glimepiride. 2. To assess the safety and tolerability of ertugliflozin.

Inclusion criteria

  • Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metaformin

Links